Navigation Links
New Inspirational Memoir Aims to Support Individuals Battling Depression

POUGHKEEPSIE, N.Y., Sept. 10, 2012 /PRNewswire/ -- A new book released today chronicles one woman's 30-year battle with major depression and sheds light on how a novel, non-drug therapy saved her life. 3,000 Pulses intimately documents 62-year-old Martha Rhodes' nearly lifelong journey with depression and gives a harrowing yet inspirational account of how it is possible to reclaim your life from the powerful grip of mental illness and attempted suicide.

"I wrote this book to help the millions of people who are suffering from depression realize that they are not alone and there is help out there," said Rhodes. "For me, transcranial magnetic stimulation, or TMS, made all the difference and my wish is that 3,000 Pulses provides others with a beacon of hope that they, too, can find peace."

Rhodes, a former New York advertising executive who seemingly had it all, experienced depressive symptoms as a teenager but wasn't officially diagnosed with major depressive disorder until her late thirties. Rhodes took antidepressant medications for about fifteen years, but over time, the medications stopped working or the side effects became intolerable. Similar to Rhodes, an estimated 4 million people in the U.S. do not benefit from standard treatments for depression, even after repeated treatment attempts. Before Rhodes found relief with TMS, she was at a point in her life where she felt nothing mattered and was ready to give up.

The title 3,000 Pulses is based on the number of highly-focused, magnetic pulses delivered during a typical TMS treatment session to stimulate function in targeted regions of the brain thought to control mood. The book is now available for purchase at

Rhodes co-authored 3,000 Pulses with Dr. Randy Pardell, MD, DFAPA, Director of Riverview Psychiatric Medicine, who has witnessed firsthand the positive impact of TMS on his patients' lives.

"I have patients who suffered from severe depression for years and experienced remarkable improvements following TMS therapy after little or no response to other antidepressant medications," Pardell said. "I hope that in reading Martha's story, others living with depression will be encouraged to explore new options to treat their symptoms."

About Transcranial Magnetic Stimulation
TMS is a noninvasive, non-systemic therapeutic device that uses short pulses of a magnetic field to stimulate nerve cells in the area of the brain thought to control mood. This pulsed magnetic field may have a positive effect on the brain's neurotransmitters' levels. When used as an antidepressant therapy, TMS produces a clinical benefit without the systemic side effects typical with oral medications and has no adverse effects on cognition as occurs with electroconvulsive therapy. NeuroStar TMS Therapy® is an FDA-cleared non-drug therapy for patients with depression who have not benefitted from one prior antidepressant medication. TMS Therapy is available by prescription only and delivered under the supervision of a psychiatrist. To learn more visit:

About Depression
Depression is a serious illness that affects about 20 million Americans annually. People with depression may experience a range of physically and emotionally debilitating symptoms, including anxiousness, sadness, irritability, fatigue, changes in sleep patterns, loss of interest in previously enjoyable activities and digestive problems. Each year in the U.S., more than 30,000 people die by suicide, 60 percent of whom suffer from depression.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma Industry Stretching Every Dollar: New Study Finds Rise in Outsourcing of Key Support Functions
2. FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
3. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
4. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
5. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Minneapolis-St. Paul Parents to Vaccinate Preteens and Teens
6. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
7. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
8. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Nashville Parents to Vaccinate Preteens and Teens
9. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
10. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges St. Louis Parents to Vaccinate Preteens and Teens
11. USPIs Physician Strategy Group Partners with Provista to Support their Affiliated Physician Practices
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
(Date:11/24/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Piper ... public is welcome to participate in the conference ... Jaffray Annual Healthcare ConferencePresenter:  , Ron Squarer, Chief ... Eastern Time Webcast: , ...
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and ... signed an agreement for DILON to distribute GE,s Discovery ... the globe. The signing of this distribution agreement will provide ... Molecular Breast Imaging system and is considered an initial ... better healthcare solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
Breaking Medicine News(10 mins):